Laure Carcaillon-Bentata is specialized in epidemiology, statistics and public health. For more than 15 years, her professional career has focused on the epidemiology of aging with a particular expertise in neurodegenerative diseases, frailty, multimorbidity and functional health.
Her doctoral and post-doctoral training at Inserm, conducted within two research teams under the direction of Dr Pierre-Yves Scarabin and Prof Jean-François Dartigues, focused on the association of hemostatic biomarkers with cardio-neuro-vascular and dementia risk. After defending her thesis in 2010, she completed a postdoctoral stay in Spain, at the Foundation for Biomedical Research, where she extended her research to the concept of frailty in geriatrics and the role of sex hormones in the aging process. In 2014, she joined the French national agency for public health where she coordinated the surveillance of neurodegenerative diseases and structured elderly health surveillance. She conducted numerous epidemiological studies based on French medico-administrative databases (SNDS): evaluation for the production of surveillance indicators, development of algorithms, matching to survey data, cohort studies. She has also participated in the elaboration of large population health surveys (Baromètres Santé, Enquêtes autonomies…), designed and developed new indicators for public health decision support, co-piloted a measure of the 2014-19 neurodegenerative diseases plan aiming at making operational the data of the National Alzheimer Bank for research. More recently, she participated at the national and European level in the evaluation of the impact of the Covid-19 related health crisis on population health, particularly on chronic diseases and on the occurrence of Covid-long. She has been involved as a task leader in 3 European joint actions related to frailty on the one hand and Covid-19 on the other hand.
Currently Scientific Officer of the BPE platform (Inserm CIC 1401 de Bordeaux), Laure Carcaillon-Bentata designs and coordinates the implementation of real life pharmaco-epidemiology studies, in collaboration with French and international partners. She is also involved in the supervision of master and PhD students. She has published more than 65 articles and 10 reports and book chapters in peer reviewed journals.